Navigation Links
TransCelerate BioPharma Inc. Grows, Strengthens Novel Effort to Accelerate Drug Development
Date:4/15/2013

PHILADELPHIA, April 15, 2013 /PRNewswire/ -- TransCelerate BioPharma Inc. ("TransCelerate") today announced that six new pharmaceutical companies have joined as members of the independent non-profit entity formed to assess, refine and create processes to bring innovative new medicines to the public faster. The addition of the new members to TransCelerate marks a major milestone since the organization's founding by ten healthcare and pharmaceutical companies in September 2012. The new member companies include Astellas Pharma Inc., the first member of TransCelerate headquartered in Japan, Biogen Idec, Braeburn Pharmaceuticals, EMD Serono, Inc. (a subsidiary of Merck KGaA, Darmstadt, Germany), Forest Research Institute (a subsidiary of Forest Laboratories, Inc.) and Onyx Pharmaceuticals.

By joining TransCelerate, each of the new companies will contribute financial and other resources, including personnel, to solve industry-wide challenges in a collaborative environment. With these six new members, combined with the ten original founding members, total membership in TransCelerate now stands at 16 companies.

"We are thrilled to expand the membership of TransCelerate BioPharma with these six new companies, we welcome them as members and we look forward to working with them," said Dalvir Gill , PhD, Chief Executive Officer of TransCelerate. "With the addition of these new members, TransCelerate extends its ability to impact global R&D and advance healthcare solutions worldwide."

As initial areas of focus, TransCelerate seeks to provide the following solutions: development of risk-based site monitoring approach and standards, development of a shared user interface for investigator site portals, mutual recognition of study site qualification and training, development of clinical data standards, and establishment of a comparator drug supply m
'/>"/>

SOURCE TransCelerate BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Biopharmaceutical Companies Transform Clinical Trial Strategies for Success in Global Marketplace
2. Americas Biopharmaceutical Companies Commitment to Research Remains Strong Despite Challenges
3. Absorption Systems Partners with Synerzys to Promote Biopharmaceutics Classification System (BCS) Testing of Drugs
4. In Q1 Public Biopharmas Shift Fundraising into Overdrive
5. Array BioPharma Announces Updates on ARRY-520 Clinical Data at the 2013 International Myeloma Workshop
6. Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
7. First Patients Dosed in Proof-of-Concept Clinical Study of Alder Biopharmaceuticals Lead Therapeutic Candidate for Treatment of Migraine, ALD403
8. Plato BioPharma Presenting Preclinical capabilities at PKPD Summit Boston
9. Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results
11. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Fourth Quarter and Year-End 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 7, 2015  New study findings reveal that more ... surgery for prostate cancer . ... their findings at the Canadian Urological Association annual meeting ... further suggest that prostate cancer patients who undergo radiation ... invasive urologic procedures due to treatment complications. They analyzed ...
(Date:7/7/2015)... , July 7, 2015 ... the governing body of swimming in the country, announced ... Championships - 2015. The championships will be organized at ... Complex, Balewadi, Pune from 13th ... http://photos.prnewswire.com/prnh/20150707/10126361 ) , Over 1,400 participants representing ...
(Date:7/6/2015)... 6, 2015  Student-athletes at community colleges across ... a recently established partnership between ImPACT Applications, Inc. ... . The partnership enables member institutions of Student ... ® concussion baseline and post-injury testing for ... community colleges in California . ...
Breaking Medicine Technology:New Study Shows Surgery Has Less Side Effects and Long-Term Issues Over Radiation for Treating Prostate Cancer 2New Study Shows Surgery Has Less Side Effects and Long-Term Issues Over Radiation for Treating Prostate Cancer 3New Study Shows Surgery Has Less Side Effects and Long-Term Issues Over Radiation for Treating Prostate Cancer 4Swimming Federation of India Announces 32nd Sub Junior and 42nd Junior Glenmark National Aquatic Championships at Shree Shiv Chhatrapati Sports Complex, Balewadi Pune From 13th to 19th July, 2015 2Swimming Federation of India Announces 32nd Sub Junior and 42nd Junior Glenmark National Aquatic Championships at Shree Shiv Chhatrapati Sports Complex, Balewadi Pune From 13th to 19th July, 2015 3California Community College Athletic Departments to Benefit from ImPACT Concussion Baseline Testing Offered by Student Insurance 2California Community College Athletic Departments to Benefit from ImPACT Concussion Baseline Testing Offered by Student Insurance 3
... SUTIMCo International, Inc. (Pink Sheets: SUTI ) ... corporate executive to the 125th Annual Meeting of The ... in New Orleans.   For over a century, AOAC ... well as proficiency testing and accreditation programs for laboratories. ...
... 2011 HemaQuest Pharmaceuticals, Inc. (HemaQuest), a biotechnology company ... disorders, announced today that it has completed enrollment in ... patients with sickle cell disease. The study, initiated in ... patients in clinical sites in the US, Canada, Jamaica, ...
Cached Medicine Technology:SUTIMCo International Inc. to Attend 125th AOAC Annual Meeting 2SUTIMCo International Inc. to Attend 125th AOAC Annual Meeting 3HemaQuest Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease 2HemaQuest Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease 3
(Date:7/7/2015)... ... July 07, 2015 , ... Nationally-renowned attorneys in ... new website, the Invokana Ketoacidosis Lawsuit Center . The website provides information ... resource for persons wishing to learn more about Invokana lawsuits for kidney problems, ...
(Date:7/7/2015)... ... July 07, 2015 , ... CSG Government Solutions, ... by the Department of Vermont Health Access to provide Quality Assurance (QA) and ... and Integrated Contact Center System project. , Vermont is implementing a strategic approach ...
(Date:7/6/2015)... Ca (PRWEB) , ... July 06, 2015 , ... Respected ... awards in 2015, marking him as an attorney who has sharp legal ... received both a Client Distinction Award for 2015 from Martindale-Hubbell and a Top 10 ...
(Date:7/6/2015)... Angeles, CA (PRWEB) , ... July 06, 2015 , ... On June 22, 2015, Fox News in a report titled ... by the time they turn age 35 a quarter of all women in the U.S. will ... hair loss is stigmatized and rarely discussed. One woman, a former beauty queen, who ...
(Date:7/6/2015)... ... ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a value of more ... of over 3.2 percent in the years to come to hit the USD 6.9 ... an anticipated launch of a number of promising pipeline candidates and an increase in ...
Breaking Medicine News(10 mins):Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 3Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2
... Alan Mozes HealthDay Reporter , WEDNESDAY, July 20 ... shorter people to develop cancer, new British research says. ... cancer, leukemia or melanoma appears to go up about 16 ... "Taller women in our study had increased risk of ...
... Neurologist Michele Tagliati, MD, director of the Movement ... an elite international task force commissioned by the ... on deep brain stimulation for dystonia, an uncommon ... The resulting articles, describing the data ...
... , WEDNESDAY, July 20 (HealthDay News) -- In a ... Wednesday approved the blood thinner Brilinta (ticagrelor) for use ... their odds for heart attack and death. Acute ... or heart attack linked to lowered blood flow to ...
... HealthDay Reporter , WEDNESDAY, July 20 (HealthDay News) -- ... disease as a major health threat, fearing its onset nearly ... Germany, Poland, Spain and the United States, the poll also ... to visit a doctor if they or a loved one ...
... Reporter , WEDNESDAY, July 20 (HealthDay News) -- The race ... New technology promises to cut costs while speeding the amount ... and potentially provide a personalized report of health risks and ... was first mapped in 2001 and cost roughly $1 billion ...
... (HealthDay News) --, Liars can control certain facial expressions when ... time, a new study shows. The researchers noted the ... conducting the study, scientists randomly asked 60 people to either ... pair of movie tickets from an envelope. While being interviewed, ...
Cached Medicine News:Health News:Study Contends Taller People at Heightened Cancer Risk 2Health News:Study Contends Taller People at Heightened Cancer Risk 3Health News:Cedars-Sinai movement disorders expert on international task force for dystonia treatment 2Health News:Cedars-Sinai movement disorders expert on international task force for dystonia treatment 3Health News:Cedars-Sinai movement disorders expert on international task force for dystonia treatment 4Health News:FDA Approves Blood Thinner Brilinta for Heart Patients 2Health News:International Poll Shows Many Fear Alzheimer's as Much as Cancer 2Health News:International Poll Shows Many Fear Alzheimer's as Much as Cancer 3Health News:Cheaper DNA Sequencing Coming Closer 2Health News:Cheaper DNA Sequencing Coming Closer 3Health News:Scrutinizing Faces Might Catch Liars, Study Finds 2
ThermalSeal RT (2mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates....
Sealing tape, slightly stiffer than Polyolefin tape....
Sealing tape featuring 3M adhesive technology. Compatible with DMSO. Good optical quality. Minimal autofluorescence....
Acetate Plate Sealers 100/Box...
Medicine Products: